Related Experiment Video
Updated: Aug 5, 2026
11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
A Personalized Haplotype-Resolved Near-Gapless Genome Framework for Somatic Variant Discovery in Hepatocellular
Jiazheng Lin1, Yao Xiao2,3,4, Shuangzi Luo1
1Hunan Research Center of the Basic Discipline for Cell Signaling, Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha, Hunan, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|July 28, 2026
Summary
Creating personalized genome references for hepatocellular carcinoma (HCC) improves cancer analysis. This patient-centric approach reveals more genetic variations, including in complex regions, enhancing tumor detection and characterization.
Area of Science:
- Genomics
- Cancer Research
- Bioinformatics
Background:
- Universal reference genomes limit detection of patient-specific variations in complex genomic regions.
- Hepatocellular carcinoma (HCC) analysis is challenged by these limitations, hindering comprehensive understanding of tumor heterogeneity.
Purpose of the Study:
- To develop and validate a patient-specific, haplotype-resolved genome assembly framework for HCC.
- To improve the identification of somatic alterations, including structural variants and non-coding variations, in HCC tumors.
Main Methods:
- Generated personalized, haplotype-resolved genome assemblies using PacBio HiFi, Oxford Nanopore, and Hi-C sequencing from paired HCC tumor and normal tissues.
- Utilized patient-specific assemblies as references for tumor analysis, improving read alignment and variant detection.
- Integrated multi-omic data, including transcriptomics, to identify and prioritize candidate regulatory alterations.
Main Results:
- Patient-specific assemblies significantly improved read alignment and variant detection compared to standard references (GRCh38).
- Identified numerous somatic small and structural variants, including those missed by universal references, and revealed tumor-associated changes in centromeric regions.
- Discovered allele-specific expression in 205 gene pairs and prioritized regulatory alterations in MET and HSD17B2.
Conclusions:
- A patient-centric genome assembly framework enhances the resolution of coding and non-coding somatic alterations in HCC.
- This approach provides a more accurate and comprehensive view of tumor genomics, complementing standard references.
- The findings establish a foundation for future large-scale validation and clinical application in HCC.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:30Histone Variants at the Centromere
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...